Clinical Trial Update: An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy [Phase 2]

View source ↗

Summary

This document reports an extension Phase 2 trial evaluating TEV-56286 for relief of symptoms in Multiple System Atrophy. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• TEV-56286

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D LLC | Conditions: Multiple System Atrophy | Phase 2 | Status: RECRUITING